Template:Did you know nominations/Prothrombin G20210A

The following discussion is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.

The result was: promoted by PumpkinSky talk 23:23, 25 January 2012 (UTC)

Prothrombin G20210A

(

)

... that prothrombin G20210A carriers who take oral contraceptives are at a 15-fold increased risk of developing blood clots in their veins (venous thrombosis)?

Comment: The sentence that the hook is sourced to combines two primary sources: Heterozygous factor V Leiden carriers or prothrombin 20210A carriers have a 15- to 30-fold increased risk of thrombosis when they use oral contraceptives.^84,105[1] The abstract of the factor V Leiden paper (ref 84) gives an increased incidence of 34.7-fold, while the G20210 paper (105) gives an increased incidence of 16.3-fold, thus the range in the italicized sentence above.

Created/expanded by Biosthmors (talk). Self nom at 19:52, 23 January 2012 (UTC)

At 1620 bits (250 words) I think this scrapes past the length criterion. It also passes on date of creation, sourcing and hook. Cwmhiraeth (talk) 09:23, 25 January 2012 (UTC)